VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Feline herpesvirus 1 UL23 mutant vaccine
Vaccine Information
  • Vaccine Name: Feline herpesvirus 1 UL23 mutant vaccine
  • Target Pathogen: Feline herpesvirus 1
  • Target Disease: Feline viral rhinotracheitis
  • Product Name: C7301dlTK
  • Vaccine Ontology ID: VO_0002958
  • Type: Live, attenuated vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Cat
  • UL23 gene engineering:
    • Type: Gene mutation
    • Description: This UL23 mutant is from Felid herpesvirus 1 (Yokoyama et al., 1996).
    • Detailed Gene Information: Click Here.
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Cat Response

  • Persistence: A UL23 mutant is attenuated in cats (Yokoyama et al., 1996).
  • Efficacy: A UL23 mutant induces significant protection in cats from wild type FHV-1 4 weeks after vaccination (Yokoyama et al., 1996).
References
Yokoyama et al., 1996: Yokoyama N, Maeda K, Tohya Y, Kawaguchi Y, Shin YS, Ono M, Ishiguro S, Fujikawa Y, Mikami T. Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats. Archives of virology. 1996; 141(3-4); 481-494. [PubMed: 8645090].